<?xml version="1.0" encoding="UTF-8"?>
<p id="Par29">This paper outlines the design of one study within the PanCareLIFE initiative that has two separate research aims. Female CCS from ten different institutions from seven European countries will be included to validate previously identified genetic polymorphisms associated with gonadal impairment and to identify 
 <italic>novel</italic> SNPs that are independently associated with chemotherapy induced gonadal impairment in female CCS.
</p>
